NCT05277051 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05277051
Title	First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	GlaxoSmithKline
Indications	head and neck squamous cell carcinoma breast cancer ovary epithelial cancer colorectal cancer stomach cancer endometrial cancer lung non-small cell carcinoma clear cell renal cell carcinoma
Therapies	GSK4381562 Dostarlimab-gxly + EOS-448 + GSK4381562 Dostarlimab-gxly + GSK4381562
Age Groups:	senior \| adult
Covered Countries	USA \| GBR \| FRA \| ESP \| CAN \| AUS

NCT05277051
Clinical Trial Detail